TrialDiabetes, obesity & metabolism2026

Efficacy and hypoglycaemia outcomes of once-weekly insulin icodec versus once-daily basal insulin comparators across baseline HbA1c, BMI and duration of type 2 diabetes subgroups: A post hoc analysis of ONWARDS 1-5.

Alice Y Y Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.